We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Electronic Cigarettes Have Minimal Effects on Heart Function

By HospiMedica International staff writers
Posted on 05 Sep 2012
A new study suggests that electronic cigarettes, which simulate the effect of smoking by producing an inhaled vapor, appear to be far less harmful to myocardial function (MF) than regular cigarettes. More...


Researchers at the Onassis Cardiac Surgery Center (Athens, Greece) conducted a study to measure the acute effects of electronic cigarettes on MF, using echocardiography and hemodynamic measurements (blood pressure and heart rate). Study participants included 20 healthy young daily smokers aged 25-45 years after smoking one tobacco cigarette, and 22 daily electronic cigarette users of similar age after using the device for 7 minutes. The researcher studied experienced users of electronic cigarettes because they use the device more intensively than first-time users; as a result, users of electronic cigarettes had a 44% higher lifetime tobacco-smoking exposure compared to current smokers.

The researchers found that smoking one tobacco cigarette led to significant defects in the diastolic phase of left ventricular function, with four echocardiographic parameters indicating worsening function. In contrast, none of the echocardiographic parameters showed any significant worsening in subjects after using the electronic cigarette. Smoking a tobacco cigarette also had important hemodynamic consequences, with significant increases in systolic and diastolic blood pressure and in heart rate. In contrast, electronic cigarettes produced only a slight elevation in diastolic blood pressure. The study was presented at the European Society of Cardiology (ESC) annual conference, held during August 2012 in Munich (Germany).

“It is too early to say whether the electronic cigarette is a revolution in tobacco harm reduction but the potential is there,” said lead author and study presenter Konstantinos Farsalinos, MD. “It is the only available product that deals with both the chemical (nicotine delivery) and psychological addiction to smoking. Laboratory analyses indicate that it is significantly less toxic and our study has shown no significant defects in cardiac function after acute use.”

The electronic cigarettes consisted of a cartridge containing a liquid with a nicotine concentration of 11mg/mL and a battery powered heating element that evaporates the liquid, simulating the effect of smoking by producing an inhaled vapor that is less toxic than that of regular cigarettes. Most studies have found no trace of nitrosamines, but even in studies where nitrosamines were found, the levels detected were 500-1,400 times less than the amount present in one tobacco cigarette. This means that electronic cigarettes need to be used daily for 4-12 months to get the amount of nitrosamines present in a single tobacco cigarette.

Related Links:

Onassis Cardiac Surgery Center



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.